| | | Immunomodulatory treatment | MS form | Relapse rate before immunomodulatory treatment (per year) | Relapse rate after immunomodulatory treatment (per year) and EDSS score |
| | Patient 1 | Interferon β 1a | RRMS | 2 | 0, EDSS = 1 | | Patient 2 | Interferon β 1a | RRMS | 1 | 1, EDSS = 1 | | Patient 3 | Interferon β 1a | RRMS | 2 | 0, EDSS = 1.5 | | Patient 4 | Interferon β 1a | RRMS | 1 | 0, EDSS = 1 | | Patient 5 | Interferon β 1a | RRMS | 5 | 1.33, EDSS = 1 | | Patient 6 | Interferon β 1b | RRMS | 1 | 0, EDSS = 0 | | Patient 7 | Interferon β 1a | RRMS | 0,5 | 0, EDSS = 1 | | Patient 8 | Interferon β 1a | RRMS | 3 | 0.3, EDSS = 1 | | Patient 9 | Interferon β 1a | RRMS | 3 | 0.6, EDSS = 1 | | Patient 10 | None | RRMS | — | —, EDSS = 0.5 | | Patient 11 | None | RRMS | — | —, EDSS = 0.5 | | Patient 12 | Interferon β 1a | RRMS | 2 | 0.33, EDSS = 2 | | Patient 13 | None | RRMS | — | —, EDSS = 1 | | Patient 14 | Interferon β 1b | RRMS | 2 | 1, EDSS = 1 | | Patient 15 | Interferon β 1a | RRMS | 4 | 0.2, EDSS = 1 | | Patient 16 | Interferon β 1a | RRMS | 1 | 0.3, EDSS = 1.5 | | Patient 17 | Interferon β 1b | RRMS | 2 | 1, EDSS = 1 | | Patient 18 | Interferon β 1a | RRMS | 4 | 1, EDSS = 1.5 | | Patient 19 | Interferon β 1a switched with interferon β 1b | RRMS then SPMS | 0.25 | 0, EDSS = 3.5 | | Patient 20 | None | RRMS | — | —, EDSS = 1 | | Patient 21 | Interferon β 1a | RRMS | 1 | 0.2, EDSS = 1 |
|
|
